Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00678457 · ClinicalTrials.gov registry record · Phase 2
Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00678457 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 40 participants.
The verdict
NCT00678457, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study would like to test whether the combination of ondansetron and olanzapine will be superior to placebo at decreasing self-reported heavy drinking among early onset alcoholics.
Interventions
- DRUG Placebo
- DRUG Ondansetron
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00678457
The ClinicalTrials.gov registry entry for NCT00678457 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00678457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00678457 about?
NCT00678457 is a clinical study titled "Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial". This study would like to test whether the combination of ondansetron and olanzapine will be superior to placebo at decreasing self-reported heavy drinking among early onset alcoholics.
What is the current status of trial NCT00678457?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2007-01. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00678457?
The interventions under investigation include: Placebo (DRUG), Ondansetron (DRUG), Olanzapine (DRUG).
Who is sponsoring clinical trial NCT00678457?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.